Terry Cook

Terry Cook has extensive experience in the pharmaceutical industry, working in various roles as a medical writer. They have previously worked for companies such as Century Therapeutics, Inc, Bristol Myers Squibb, Juno Therapeutics, Inc. (a Celgene company), Gilead Sciences, Genzyme, Research Pharmaceutical Services, NeoRx, and Immunex. Throughout their career, they have held positions of increasing responsibility, including Senior Director and Director of Early Clinical Development. Terry has been involved in clinical research, medical writing, and document management, collaborating with internal and external stakeholders. They have experience in a range of therapeutic areas, including oncology, multiple myeloma, non-Hodgkin's lymphoma, and various solid tumors.

Terry Cook holds a PhD in Pharmacology from the University of Washington, which was completed between the years 1994-2001. Prior to that, they earned a BA in Chemistry from The College of Wooster, from 1992-1994. Terry also studied music, specifically general music, at Northwestern University from 1989-1991.